| RS1344212943 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease, type IV |
| RS1344213916 |
FBXO7
|
Health Risk |
Pathogenic/Likely pathogenic |
Parkinsonian-pyramidal syndrome, Parkinsonian-pyramidal syndrome |
| RS1344231723 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Gorlin syndrome |
| RS1344235154 |
FBP1
|
Health Risk |
Pathogenic |
Fructose-biphosphatase deficiency, Fructose-biphosphatase deficiency |
| RS1344249067 |
KMT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1344258746 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1344266804 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1344275862 |
BAG3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS1344288054 |
PDE6C
|
Health Risk |
Likely pathogenic |
— |
| RS1344296862 |
ABCA12
|
Health Risk |
Pathogenic |
— |
| RS1344296865 |
SMOC1
|
Health Risk |
Pathogenic |
Microphthalmia with limb anomalies, Microphthalmia with limb anomalies |
| RS1344296942 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1344304906 |
SOS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 9, SOS2-related disorder |
| RS1344332366 |
GUSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 7, Mucopolysaccharidosis type 7 |
| RS1344337662 |
IGFALS
|
Health Risk |
Likely pathogenic |
— |
| RS1344342135 |
CAMK2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1344343597 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS1344368175 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1344390541 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1344396759 |
SOS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 9, Cardiovascular phenotype |
| RS1344409792 |
OTOF
|
Health Risk |
Likely pathogenic |
— |
| RS1344419982 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1344422504 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1344432803 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral arteriopathy, autosomal dominant |
| RS1344439858 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS1344477568 |
SCN9A
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS1344484845 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1344488286 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS1344509500 |
CDH23
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 12, Usher syndrome type 1D |
| RS1344522422 |
CASZ1
|
Health Risk |
Pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS1344527425 |
TPP1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Autosomal recessive spinocerebellar ataxia 7 |
| RS1344533583 |
CDC73
|
Health Risk |
Conflicting classifications of pathogenicity |
Parathyroid carcinoma, Hyperparathyroidism 2 with jaw tumors |
| RS1344548642 |
COL4A3
|
Health Risk |
Likely pathogenic |
Autosomal dominant Alport syndrome, Hematuria |
| RS1344550427 |
AP4M1
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1344551908 |
CTRC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS1344555845 |
GALNS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS1344561983 |
LDLR
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Familial hypercholesterolemia |
| RS1344567292 |
TNPO3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant limb-girdle muscular dystrophy type 1F, Autosomal dominant limb-girdle muscular dystrophy type 1F |
| RS1344567623 |
LORICRIN
|
Health Risk |
Likely pathogenic |
Loricrin keratoderma, Loricrin keratoderma |
| RS1344574242 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1344601147 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1344601362 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Infantile hypophosphatasia, Hypophosphatasia |
| RS1344607767 |
BTD
|
Health Risk |
Pathogenic |
Biotinidase deficiency, Biotinidase deficiency |
| RS1344615174 |
ALPK3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiomyopathy, familial hypertrophic 27 |
| RS1344658850 |
CLN6
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Ceroid lipofuscinosis |
| RS1344681005 |
SDHAF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary cancer-predisposing syndrome |
| RS1344698119 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1344698815 |
CHD1
|
Health Risk |
Likely pathogenic |
Pilarowski-Bjornsson syndrome, Pilarowski-Bjornsson syndrome |
| RS1344704197 |
ABCG5
|
Health Risk |
Pathogenic |
Sitosterolemia, Sitosterolemia |
| RS1344724754 |
RPE65
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 2, Retinitis pigmentosa 20 |
| RS13447324 |
MC4R
|
Health Risk |
Pathogenic |
Obesity, Schizophrenia |
| RS13447325 |
MC4R
|
Health Risk |
Conflicting classifications of pathogenicity |
Obesity, BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 |
| RS13447326 |
MC4R
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS13447329 |
MC4R
|
Health Risk |
Conflicting classifications of pathogenicity |
Obesity, BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 |
| RS13447331 |
MC4R
|
Health Risk |
Conflicting classifications of pathogenicity |
Obesity, BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 |
| RS13447332 |
MC4R
|
Health Risk |
Pathogenic/Likely pathogenic |
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, MC4R-related disorder |
| RS13447333 |
MC4R
|
Health Risk |
Pathogenic/Likely pathogenic |
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 |
| RS13447338 |
MC4R
|
Health Risk |
Pathogenic |
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, MC4R-related disorder |
| RS13447339 |
MC4R
|
Health Risk |
Pathogenic/Likely pathogenic |
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, Obesity |
| RS1344745708 |
SLC25A12
|
Health Risk |
Pathogenic |
— |
| RS1344759224 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1344768030 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS1344783415 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS1344786039 |
CAD
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1344786638 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1344808304 |
SFRP4
|
Health Risk |
Likely pathogenic |
Pyle metaphyseal dysplasia, Pyle metaphyseal dysplasia |
| RS1344820986 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS1344826245 |
APRT
|
Health Risk |
Likely pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS1344839231 |
TYMP
|
Health Risk |
Pathogenic |
— |
| RS1344854036 |
AHI1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Joubert syndrome 3 |
| RS1344892313 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS1344899647 |
UMPS
|
Health Risk |
Likely pathogenic |
Oroticaciduria, Oroticaciduria |
| RS1344931712 |
APPL1
|
Health Risk |
Likely pathogenic |
— |
| RS1344931713 |
MYO1E
|
Health Risk |
Pathogenic |
— |
| RS1344972426 |
AP2M1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1344999827 |
OTOG
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 18B, Autosomal recessive nonsyndromic hearing loss 18B |
| RS1345014390 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS1345024890 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS1345028760 |
SLC25A1
|
Health Risk |
Pathogenic |
— |
| RS1345028835 |
MCPH1
|
Health Risk |
Pathogenic |
— |
| RS1345036090 |
GSR
|
Health Risk |
Pathogenic |
Hemolytic anemia due to glutathione reductase deficiency, Hemolytic anemia due to glutathione reductase deficiency |
| RS1345086570 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1345120527 |
DGUOK
|
Health Risk |
Pathogenic |
— |
| RS1345121557 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS1345146274 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS1345148257 |
PDE4D
|
Health Risk |
Conflicting classifications of pathogenicity |
Acrodysostosis 2 with or without hormone resistance, Acrodysostosis 2 with or without hormone resistance |
| RS1345151578 |
SACS
|
Health Risk |
Pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS1345175795 |
SLC26A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Pendred syndrome, Autosomal recessive nonsyndromic hearing loss 4 |
| RS1345176461 |
IRF2BPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with regression, abnormal movements |
| RS1345208839 |
MED13L
|
Health Risk |
Conflicting classifications of pathogenicity |
Dextro-looped transposition of the great arteries, Dextro-looped transposition of the great arteries |
| RS1345217165 |
CEP250
|
Health Risk |
Pathogenic |
Cone-rod dystrophy and hearing loss 2, Cone-rod dystrophy and hearing loss 2 |
| RS1345228128 |
LRSAM1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS1345239508 |
CLCNKB
|
Health Risk |
Pathogenic |
— |
| RS1345247825 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS1345279795 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1345325140 |
FBXL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 13, Mitochondrial DNA depletion syndrome 13 |
| RS1345327745 |
GYS1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to muscle and heart glycogen synthase deficiency, Glycogen storage disease due to muscle and heart glycogen synthase deficiency |
| RS1345329176 |
GLI2
|
Health Risk |
Conflicting classifications of pathogenicity |
Holoprosencephaly 9, Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome |
| RS1345403701 |
DNAI1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Kartagener syndrome |
| RS1345403982 |
SUFU
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Gorlin syndrome |